Integral Ad Science (NASDAQ:IAS) Price Target Cut to $16.00 by Analysts at Craig Hallum

Integral Ad Science (NASDAQ:IAS) had its price objective lowered by equities researchers at Craig Hallum from $18.00 to $16.00 in a note issued to investors on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the stock. Craig Hallum’s target price indicates a potential upside of 54.29% from the stock’s previous close.

Other analysts have also issued reports about the stock. Morgan Stanley lifted their target price on shares of Integral Ad Science from $12.00 to $13.00 and gave the company an “equal weight” rating in a research report on Tuesday, July 23rd. Oppenheimer reduced their price target on shares of Integral Ad Science from $20.00 to $18.00 and set an “outperform” rating on the stock in a research report on Wednesday. Raymond James boosted their price target on shares of Integral Ad Science from $13.00 to $15.00 and gave the company an “outperform” rating in a research report on Friday, August 2nd. Benchmark restated a “hold” rating on shares of Integral Ad Science in a research report on Monday, August 5th. Finally, Barclays boosted their price target on shares of Integral Ad Science from $12.00 to $13.00 and gave the company an “equal weight” rating in a research report on Monday, August 5th. Three investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $15.70.

Integral Ad Science Stock Performance

IAS traded down $0.40 during trading on Wednesday, hitting $10.37. The stock had a trading volume of 170,925 shares, compared to its average volume of 1,385,157. The company has a current ratio of 3.71, a quick ratio of 3.76 and a debt-to-equity ratio of 0.07. The firm has a market cap of $1.69 billion, a PE ratio of 53.83, a P/E/G ratio of 1.46 and a beta of 1.52. The company has a 50 day simple moving average of $11.11 and a 200-day simple moving average of $10.47. Integral Ad Science has a 12 month low of $7.98 and a 12 month high of $17.53.

Integral Ad Science (NASDAQ:IAS) last posted its quarterly earnings results on Tuesday, November 12th. The company reported $0.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.08 by $0.02. The company had revenue of $133.50 million for the quarter, compared to analyst estimates of $138.06 million. Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. The business’s quarterly revenue was up 11.0% on a year-over-year basis. During the same period last year, the business posted ($0.09) EPS. Analysts expect that Integral Ad Science will post 0.25 EPS for the current year.

Insiders Place Their Bets

In related news, CEO Lisa Utzschneider sold 10,481 shares of the business’s stock in a transaction that occurred on Monday, October 7th. The shares were sold at an average price of $10.11, for a total transaction of $105,962.91. Following the completion of the sale, the chief executive officer now directly owns 239,709 shares of the company’s stock, valued at $2,423,457.99. The trade was a 4.19 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CFO Tania Secor sold 5,240 shares of the business’s stock in a transaction that occurred on Monday, October 7th. The stock was sold at an average price of $10.11, for a total transaction of $52,976.40. Following the sale, the chief financial officer now directly owns 248,223 shares of the company’s stock, valued at approximately $2,509,534.53. This trade represents a 2.07 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 23,006 shares of company stock valued at $240,296. Insiders own 2.00% of the company’s stock.

Institutional Investors Weigh In On Integral Ad Science

Several large investors have recently bought and sold shares of IAS. Vanguard Group Inc. increased its stake in Integral Ad Science by 7.0% in the first quarter. Vanguard Group Inc. now owns 8,673,229 shares of the company’s stock valued at $86,472,000 after purchasing an additional 566,982 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund bought a new stake in Integral Ad Science in the second quarter valued at approximately $4,724,000. Nisa Investment Advisors LLC boosted its holdings in shares of Integral Ad Science by 449,805.3% in the second quarter. Nisa Investment Advisors LLC now owns 427,410 shares of the company’s stock valued at $4,154,000 after buying an additional 427,315 shares during the period. Clearbridge Investments LLC boosted its holdings in shares of Integral Ad Science by 11.8% in the first quarter. Clearbridge Investments LLC now owns 3,906,652 shares of the company’s stock valued at $38,949,000 after buying an additional 412,044 shares during the period. Finally, Jupiter Asset Management Ltd. acquired a new position in shares of Integral Ad Science in the first quarter valued at approximately $3,257,000. Institutional investors own 95.78% of the company’s stock.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.